A GIS Approach to Staphylococcus Associated Mortality in Texas in 2005 By Samuel F. Barker, MT School of Rural Public Health Texas A&M Health Science Center.

Slides:



Advertisements
Similar presentations
NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Advertisements

Antimicrobial resistance surveillance in Ireland Results of invasive Staphylococcus aureus infection (blood) surveillance (2009Q1-4) **** Data as of 14/04/2010.
MRSA Found in U.S. Wastewater Treatment Plants.  MRSA is a type of staph bacteria that is resistant to certain antibiotics called beta-lactams (Centers.
Population- based Surveillance of Reportable Diseases in Nursing Home Facilities in Nebraska Manjiri Joshi, MPH + Alison Keyser Metobo, MPH + + Epidemiology.
CPC #2: Fever, cough, dyspnea, and change in mental status Barbara J. Crain, M.D., Ph.D. October 7, 2008.
MRSA.
PREDICTORS OF DIABETIC WOUND HEALING BY RACIAL/ETHNIC CATEGORIES Ranjita Misra 1, Lynn Lambert 2, David Vera 3, Ashley Mangaraj 3, Suchin R Khanna 3, Chandan.
Antimicrobial Susceptibility Testing – Part II
Mobile clinics: How to improve access to health in remote areas? WHO Informal Technical Consultation BRAVE Geneva 6-7 November 2012 Dr Charles Senessie.
MRSA Methicillin Resistant Staphylococcus Aureus
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
Epidemiology and Control of Methicillin-Resistant Staphylococcus aureus in hospitals Maria Kapi,MD Registrar of Medical Microbiology Laiko General Hospital.
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
MRSA PREPARED BY SARA ABUHIMED. Methicillin-resistant Staphylococcus Aureus (MRSA) is a type of bacteria that is resistant to certain antibiotics. These.
Methicillin-Resistant Staphylococcus aureus Infections in California Hospital Patients, 1999 – 2006 Mary Tran, PhD, MPH Niya Fong, BS Microbiology California.
MRSA Definition Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium responsible for difficult-to-treat infections in humans. MRSA is by definition.
Big Bad Bugs in the Dialysis Unit Douglas Shemin, MD Kidney Diseases and Hypertension Division, Rhode Island Hospital.
Soft Tissue Infections
MRSA in Corrections Danae Bixler, MD, MPH
MRSA and VRE in a Rural Community Hospital Graduation Project 2008 Mehvish Ally.
Methicillin-resistant Staphylococcus Aureus (MRSA) By: Aaron Mohr, Taylor Host, and Kristen Sposetta.
. Nosocomial Antibiotic Resistant Organisms Copyright © Texas Education Agency, All rights reserved.
Assessing Minority Participation in Clinical Trials: Setting Attainable Goals The Minority and Women Clinical Trials Recruitment Program Department of.
Kathleen Orloski, DVM, MS Diplomate, ACVPM, Epidemiology Specialty USDA, APHIS, Veterinary Services TB Eradication Program April 5-6, 2011.
Catheter-Associated Bloodstream Infections Based on Infectious Disease Society of America guidelines Clinical Infectious Diseases 2001;32: Rey.
Methicillin-resistant Staphylococcus aureus in Loja Province, Ecuador Student Researcher: Sarah Hof Faculty Researcher: Daniel Herman, PhD Department of.
Methicillin Resistant Staphylococcus aureus Exposure Assessment in a Burn Center Environment Cassandra Andrade, Space Grant Intern Kelly Reynolds, Ph.D.,
SPM 100 Clinical Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT.
National Surveillance Estimates of Unintentional, Non-fire Related Carbon Monoxide Poisoning Jackie Clower, MPH Contractor, Air Pollution & Respiratory.
Community Acquired MRSA CA-MRSA Margaret Teitelbaum School Nurse/Health Educator Westfield High School.
SS-32 To Be or Not To Be: The Dilemma of Suicide in America.
IDO-Staph: An Ontology of Staphylococcus aureus Infectious Disease Albert Goldfain, Ph.D. Researcher, Blue Highway, Inc. Problems.
Community-acquired methicillin-resistant Staph. aureus (CA-MRSA): Amarillo experience Infectious Disease Epidemiology Work Group Texas Department of State.
Persistence and Prevalence of MRSA on Ocular Surface following Primary MSSA/MRSA Infections Darlene Miller, DHSc, MPH, CIC David Almeida, MD, PhD Eduardo.
SPM 100 Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT Clinical Skills Lab Coordinator.
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
Understanding Methicillin-Resistant Staphylococcus aureus
Methicillin-Resistant Staphylococcus Aureus (MRSA)
Cheryl Meddles-Torres, DNP, RN, FNP-C Shuang Hu
Center for Drug Evaluation and Research March 6, 2005 Bacteremia and Endocarditis: Products and Guidance Janice Soreth, MD Director Division of Anti-Infective.
Production of variation Selection for/against  Pop evolves:  cumulative change in heritable characteristics in population  Nat sel can act on pop w/o.
Gastric Cancers in Texas: Are Nitrates the Problem?
Life and Times of: Methicillin Resistant Staphylococcus Aureus (MRSA) Group 3.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
Evolution of Bacteria Joshua Jackson 2 nd Period Biology Honors.
Staph Infections. What is staph? Staphylococcus aureus, often referred to simply as “staph,” are bacteria commonly carried on the skin or in the nose.
1 A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital DIABETES Care; Aug 2006; 29,8 : FM R1 임혜원.
MRSA.
Methicillin-resistant Staphylococcus aureus (MRSA) By: Raigan Chambers.
Using Nursing Home Antibiograms To Improve Antibiotic Prescribing and Delivery Training Slides for Nursing Home Nurses Comprehensive Antibiogram Toolkit.
Pattern of Hospital-Acquired Pneumonia in Intensive Care Unit of Suez Canal University Hospital By Nermine El-Maraghy Associate Professor of Medical Microbiology.
Nosocomial Antibiotic Resistant Organisms
Antibiotic-resistant Bacteria
Antibiotic Resistance
The Laboratory diagnosis and susceptibility testing of meticilline-resistant staphylococcus aureus By: Maj Anthere Murangwa, MSC Medical Microbiologist.
Alison Keyser Metobo, MPH +
Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.
NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Diseases caused by Staph. aureus
Antibiotics sensitivity of microorganism causing nosocomial infections
Clinical impact of antibiotic-resistant Gram-positive pathogens
A GIS Approach to Staphylococcus Associated Mortality in Texas in 2005
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
MRSA=Methicillin resistant Staphylococcus aureus
Prevention and Control of MRSA vs. VRE
Can β-lactams be re-engineered to beat MRSA?
J. Segreti  Clinical Microbiology and Infection 
Presentation transcript:

A GIS Approach to Staphylococcus Associated Mortality in Texas in 2005 By Samuel F. Barker, MT School of Rural Public Health Texas A&M Health Science Center Refer all questions to:

Updates and Assumptions Oxacillin, Nafcillin, and Methicillin were treated equally to establish methicillin resistance. By definition, MRSA is genetically resistant to: Betalactams Cephalosporins Carbapenems Intermediate resistance was treated as resistant based on clinical treatment protocols.

Texas Death Cohort ,924 deaths on record 439 records listed Staphylococcus sp. as a contributing cause 223 records listed Staphylococcus sp. as the underlying cause 210 records requested 114 complete records received

Texas Staphylococcal Death Cases in 2005

Response rates to requests for laboratory records by facilities in which staphylococcal deaths occurred in Texas, Response Adequate information77 (68.2)114 (51.2) No culture reports12 (10.6)40 (17.9) No response24 (21.2)69 (30.9) Total113 (100)223 (100) 2 Medical records requested on 210 deaths Number ( %) 1 Medical records requested on sample of 197 total deaths

2004 RaceMRSA # (%) MSSA # (%) White †39 (67.2)19 (37.8) Black5 (71.4)2 (28.6) Other8 (66.7)4 (33.3) Race/Ethnicity † Reference group

Culture sources of staphylococcal infections resulting in death in Texas, Culture Source Blood 53 (68.8)51 (44.7) Sputum 11 (14.3)36 (31.6) Bronchial Wash 3 (3.9)7 (6.1) Respiratory 3 (3.9)5 (4.4) Catheter Tip 2 (2.6)0 (0.0) Skin 1 (1.3)0 (0.0) Spinal fluid 2 (2.6)0 (0.0) Wound 1 (1.3)10 (8.8) Urine 0 (0.0)4 (3.5) Arterial Line 0 (0.0)1 (0.9) Not Listed 1 (1.3)0 (0.0) Total 77 (100)114 (100) 2 Medical records requested on 210 deaths Number ( %) 1 Medical records requested on sample from 197 deaths

Number of deaths per year reporting staphylococcus as a contributing COD

Number of deaths per year reporting staphylococcus as the underlying COD

Staphylococcal species responsible for infections resulting in death in Texas,

Demographic variables associated with deaths due to MRSA compared with deaths due to MSSA Sex MRSA # (%) MSSA # (%) MRSA # (%) MSSA # (%) Male † 33 (64.7)18 (35.3)50 (80.6)12 (19.4) Female 19 (73.9) 733 (73.3)12 (26.7) † Reference group

Demographic variables associated with deaths due to MRSA compared with deaths due to MSSA AgeMRSA # (%) MSSA # (%) MRSA # (%) MSSA # (%) Mean Age ≥ 30 † 5(55.6) 4(44.4) 6(85.7) 1(14.3) (69.6) 7(30.4)18(85.7) 3(14.3) > 60 31(68.9)14(31.1)59(74.7)20(25.3) † Reference Group

Association of site of staphylococcal infection with MRSA compared with MSSA

Percent antibiotic resistance of staphylococcal species as reported on susceptibility tests for persons dying of staphylococcal infections in Texas, *Data are based on hospital laboratory reports. No vancomycin resistant staphylococcus have been confirmed in Texas.

Antibiotic Classification

Percent antibiotic class resistance of staphylococcal species as reported on susceptibility tests for persons dying of staphylococcal infections in Texas,

2005 Texas Population and Staph Death Count

2005 Texas Population and Staph Death Rate (per 100,000)

2005 Texas Population and Staphylococcal Death (Per 100,000)

Staphylococcal Death Count and Rate (per 100,000)

Rural Urban Continuum Code by Staph Death Count

RUC Code and Staph Death Rate (per 100,000)

Staphylococcal Death by Rural-Urban Continuum Code (Per 100,000)

Special Thanks to J. Charles Huber Jr, PhD Asst. Professor of Biostatistics Dept. of Epidemiology and Biostatistics Texas A&M Health Science Center School of Public Health